Ventricular Arrhythmia
📧 Sign up to get email alerts when something new happens for Ventricular Arrhythmia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-09-12FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for sotalol hydrochloride from Oxford Pharmaceuticals, LLC under an ANDA.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: Preventive VT Substrate Ablation in Ischemic Heart Disease [Phase 3]
Phase 3 clinical trial update on preventive substrate ablation for ventricular tachycardia in ischemic heart disease (status: unknown).
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Extravascular ICD Pivotal Study [NA]
Medtronic's Extravascular ICD pivotal study has completed and posted results.
-
FDA approval · 2023-06-15FDA Approved: BETAPACE — Supplemental Application (Legacy Pharma USA, Inc.)
The FDA approved a supplemental application for BETAPACE (sotalol hydrochloride) from Legacy Pharma USA, Inc.
-
FDA approval · 2023-02-28FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approved a supplemental application for Sotalol hydrochloride from Oxford Pharmaceuticals, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-08-26FDA Approved: MEXILETINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original Abbreviated New Drug Application for mexiletine hydrochloride by Rising Pharma Holdings, making a generic antiarrh…
-
CLINICAL_TRIALS trial_result · 2022-07-11Clinical Trial Update: Safety Assessment for Sotalol Protocol in Outpatient Unit [Phase 4]
A Phase 4 safety assessment update for a sotalol protocol in outpatient settings investigating arrhythmia conditions and potential proarrhyt…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Extravascular ICD Pilot Study [NA]
A completed clinical trial update for an Extravascular ICD pilot study presented results in 2022.
-
CLINICAL_TRIALS trial_result · 2021-10-19Clinical Trial Update: GANGlion Stellate Block for Treatment of Electric storRm (GANGSTER Trial) [Phase 3]
Phase 3 clinical trial update for GANGlion Stellate Block therapy targeting ventricular arrhythmias, including ventricular tachycardia and r…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: Intramural Needle Ablation for the Treatment of Refractory Ventricular Arrhythmias [NA]
A completed clinical trial investigating intramural needle ablation for refractory ventricular arrhythmias; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Prophylactic Amiodarone for Shockable Cardiac Arrest [Phase 3]
Phase 3 trial update on prophylactic amiodarone for patients with shockable cardiac arrest.
-
FDA approval · 2021-06-03FDA Approved: BETAPACE — Supplemental Application (Legacy Pharma USA, Inc.)
FDA approved a supplemental application for Betapace (sotalol hydrochloride) filed by Legacy Pharma USA, Inc.
-
FDA approval · 2021-01-25FDA Approved: MEXILETINE HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Mexiletine hydrochloride as a generic drug from Ingenus Pharmaceuticals under an Original Application (ANDA214352).
-
CLINICAL_TRIALS trial_result · 2020-10-28Clinical Trial Update: Improve Sudden Cardiac Arrest Study [NA]
Clinical trial update for a study on sudden cardiac arrest and ventricular arrhythmia completed with results posted.
-
FDA approval · 2020-03-06FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (ALTATHERA Pharmaceuticals, LLC)
FDA approves a supplemental application for sotalol hydrochloride from ALTATHERA Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Sodium-glucose Co-transporter 2 Inhibitors Effects in Failing Heart Patients [Phase 4]
Phase 4 trial update evaluating SGLT2 inhibitors in patients with diabetes and heart failure, including potential effects on ventricular arr…
-
CLINICAL_TRIALS trial_result · 2019-04-09Clinical Trial Update: Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator [Phase 2]
This Phase 2 trial evaluated ventricular arrhythmia in subjects with implantable cardioverter-defibrillators or CRT-D devices; results have …
-
CLINICAL_TRIALS research · 2019-02-12Clinical Trial Update: French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator
A French national registry study enrolling patients with Tetralogy of Fallot who have an implantable cardioverter-defibrillator to collect o…
-
CLINICAL_TRIALS research · 2019-01-29Clinical Trial Update: China Structural Ventricular Arrhythmias Registry
The China Structural Ventricular Arrhythmias Registry is currently recruiting, focusing on ventricular arrhythmias.
-
CLINICAL_TRIALS trial_result · 2017-06-15Clinical Trial Update: Cardiac Complication After Vascular Surgery
Completed clinical trial from Pomeranian Medical University Szczecin evaluating cardiac complications after vascular surgery, involving abdo…
-
CLINICAL_TRIALS research · 2017-02-02Clinical Trial Update: Zero-fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for the Treatment of Ventricular Arrhythmias [NA]
Clinical trial comparing zero-fluoroscopic ablation with conventional fluoroscopic ablation for ventricular arrhythmias; current status is u…
-
CLINICAL_TRIALS research · 2016-12-13Clinical Trial Update: Effect of Radiofrequency Ablation in Patients With Ventricular Arrhythmia Undergoing CABG [NA]
This clinical trial update examines the potential use of radiofrequency ablation to treat ventricular arrhythmias in patients undergoing cor…
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Coronary Artery Bypass Graft (CABG) Patch Trial [Phase 3]
A Phase 3 CABG patch trial sponsored by NHLBI has completed; the update notes the study status but does not report results in the snippet.
-
CLINICAL_TRIALS trial_result · 2016-10-26Clinical Trial Update: NIPS to Identify High-risk Patients With ICD [NA]
Clinical trial update indicating the NIPS study to identify high-risk patients with implantable cardioverter-defibrillators has completed.
-
CLINICAL_TRIALS withdrawal · 2016-10-26Clinical Trial Update: Omega 3 Polyunsaturated Fatty Acid Supplements (PUFAs) and Microvolt T Wave Alternans (TWA) in Patients With Ventricular Arrhythmia [Phase 4]
A Phase 4 trial evaluating omega-3 polyunsaturated fatty acid supplements and microvolt T wave alternans in patients with ventricular arrhyt…